Potassium Citrate Tablet, Extended Release
Product Images NDC 16571-864

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 16571-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Potassium-citrate-01 (Potassium Citrate 01)

Label for Potassium Citrate Extended-Release Tablets, USP, 5 mEq (540 mg per tablet) by Rising Pharma Holdings, Inc. The label indicates a count of 100 tablets, with storage instructions and manufacturing details. The product is for oral use and is prescription only.*

FDA Label Image

Potassium-citrate-02 (Potassium Citrate 02)

Label for Potassium Citrate Extended-Release Tablets, USP, 1080 mg per tablet (10 mEq) by Rising Pharma Holdings, Inc. The oral tablet packaging contains 100 tablets and is marked Rx only. The label includes storage instructions and manufacturing details, with a barcode on the right side.*

FDA Label Image

Potassium-citrate-structure (Potassium Citrate Struct)

Chemical structure of potassium citrate showing the citrate ion bonded with three potassium ions and associated water molecules in a hydrate form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.